Dax1 and Nanog act in parallel to stabilize mouse embryonic stem cells and induced pluripotency

Zhang, Junlei; Liu, Gaoke; Ruan, Yan; Wang, Jiali; Zhao, Ke; Wan, Ying; Liu, Bing; Zheng, Hongting; Peng, Tao; Wu, Wei; He, Ping; Hu, Fu-Quan; Jian, Rui

doi:10.1038/ncomms6042

Download PDF

Article
Open access
Published: 06 October 2014

Dax1 and Nanog act in parallel to stabilize mouse embryonic stem cells and induced pluripotency

Junlei Zhang¹^na1,
Gaoke Liu¹^na1,
Yan Ruan²^na1,
Jiali Wang³^na1,
Ke Zhao⁴,
Ying Wan^5,6,
Bing Liu⁴,
Hongting Zheng⁷,
Tao Peng⁸,
Wei Wu⁹,
Ping He⁹,
Fu-Quan Hu¹ &
…
Rui Jian²

Nature Communications volume 5, Article number: 5042 (2014) Cite this article

5760 Accesses
48 Citations
10 Altmetric
Metrics details

Subjects

Abstract

Nanog expression is heterogeneous and dynamic in embryonic stem cells (ESCs). However, the mechanism for stabilizing pluripotency during the transitions between Nanog^high and Nanog^low states is not well understood. Here we report that Dax1 acts in parallel with Nanog to regulate mouse ESC (mESCs) identity. Dax1 stable knockdown mESCs are predisposed towards differentiation but do not lose pluripotency, whereas Dax1 overexpression supports LIF-independent self-renewal. Although partially complementary, Dax1 and Nanog function independently and cannot replace one another. They are both required for full reprogramming to induce pluripotency. Importantly, Dax1 is indispensable for self-renewal of Nanog^low mESCs. Moreover, we report that Dax1 prevents extra-embryonic endoderm (ExEn) commitment by directly repressing Gata6 transcription. Dax1 may also mediate inhibition of trophectoderm differentiation independent or as a downstream effector of Oct4. These findings establish a basal role of Dax1 in maintaining pluripotency during the state transition of mESCs and somatic cell reprogramming.

NANOG initiates epiblast fate through the coordination of pluripotency genes expression

Article Open access 21 June 2022

Nicolas Allègre, Sabine Chauveau, … Claire Chazaud

ID proteins promote the survival and primed-to-naive transition of human embryonic stem cells through TCF3-mediated transcription

Article Open access 15 June 2022

Haibin Jiang, Mingxia Du, … Jun Yang

The Wnt/TCF7L1 transcriptional repressor axis drives primitive endoderm formation by antagonizing naive and formative pluripotency

Article Open access 03 March 2023

Paraskevi Athanasouli, Martina Balli, … Frederic Lluis

Introduction

Embryonic stem cells (ESCs), derived from the inner cell mass of blastocyst-stage embryos, can maintain self-renewal and multilineage differentiation potential in vitro¹. Understanding mechanisms for maintenance of pluripotency not only promotes advances in tissue engineering, embryonic development and cancer research², but also allows generation of induced pluripotent stem cell (iPSC) technology³. Oct4 and Nanog are the most well-characterized pluripotency factors in ESCs. The Oct4/Nanog-centred regulatory network has been shown to play key roles in ESC fate determination^4,5. However, while the list of network factors is rapidly expanding^6,7, the functional relationships of these factors with Oct4 and Nanog are largely unknown.

Overexpression (OE) of Nanog blocks the differentiation of ESCs into extra-embryonic endoderm (ExEn), and confers cytokine-independent self-renewal^8,9. Mutual antagonism between Gata6 and Nanog is thought to determine ExEn versus stem cell fate¹⁰. In particular, excess Gata6 gives rise to the ExEn lineage¹¹, whereas excess Nanog results in the stem cell state. Unlike Nanog, Oct4 expression must be tightly regulated to maintain ESC pluripotency. Reduction of Oct4 expression below 50% induces differentiation into trophectoderm (TE) by upregulating transcription factors Cdx2 and Eomes. When Oct4 expression exceeds 150%, ESCs differentiate chiefly into ExEn cells with increased Gata6 expression^12,13.

Compared with the relatively uniform expression of Oct4, Nanog expression is not only heterogeneous but also dynamic in ESCs^14,15. Nanog^high ESCs possess high self-renewal efficiency, whereas Nanog^low ESCs have increased propensity to ExEn differentiation and upregulated Gata6, but do not undergo commitment¹⁵. So far, little is known about the mechanism for stabilizing pluripotency during the transition between Nanog^high and Nanog^low states. Nanog^low or even Nanog^null ESCs retain a self-renewal capacity and pluripotency, suggesting that increased Gata6 is insufficient to induce ExEn differentiation. Therefore, possibly other ESC-specific transcription factors, which should be functionally independent of Nanog, may be involved in inhibiting full activation of Gata6 and ExEn differentiation in Nanog^low/null ESCs.

Dax1 (dosage-sensitive sex reversal-AHC critical region on the X-chromosome gene 1, also known as Nr0b1) is a transcriptional repressor¹⁶ that has been identified as a major component in both Oct4-centred and Nanog-centred protein interaction networks^17,18,19. However, its mechanisms of action with respect to pluripotency are not well understood (Supplementary Table 1). Here, through systematic molecular and cellular functional analysis, we uncover a previously unknown functional relationship between Dax1 and Nanog, and suggest that these two factors function synergistically to stabilize both ESC and induced pluripotency.

Results

Dax1-knockdown ESCs can maintain self-renewal

The Dax1 gene was expressed highly in ESCs and was rapidly downregulated during differentiation^20,21, suggesting a functional role for Dax1 in maintaining pluripotency of ESCs. To investigate this, we used short hairpin RNA (shRNA) lentiviral vectors to stably knockdown (KD) Dax1 in ESCs. Seven shRNAs targeting different regions of Dax1 complementary DNA were tested. Dax1 was effectively silenced by two constructs, designated Dax1 KD-2 and Dax1 KD-5, which target the CDS (coding sequence) and 3′ untranslated region (3′ UTR), respectively (Fig. 1a,b; Supplementary Fig. 1a,b). We found that the depletion of Dax1 resulted in more differentiation-like cells and slower cell expansion compared with wild-type (WT) and luciferase KD (Luc KD, serving as a negative control) cells (Fig. 1c,d). However, Dax1 KD cells could be continuously propagated (for at least 30 passages) in the presence of leukaemia inhibitory factor (LIF) and retained the capacity to form ESC colonies (Fig. 1c). Colony formation assays showed that Dax1 KD cells formed less wholly undifferentiated alkaline phosphatase (AP)-positive colonies and more mixed (partially differentiated) colonies compared with control cells (Fig. 1e; Supplementary Fig. 1c). Consistent with the increase in partially differentiated colonies, ExEn markers (Gata6, Foxa2, Sox17, Afp, Ihh, LamininB1 and Dab2) were significantly upregulated in Dax1 KD cells as shown by quantitative reverse transcriptase–PCR (qRT–PCR) analysis (Fig. 1f). Also, there was a weak induction of mesoderm (Flk1) and TE markers (Hand1, Cdx2 and Eomes), but not of the neuroectoderm (Sox1 and Nestin) and other mesodermal markers (Brachyury and Goosecoid). Nonetheless, expression of pluripotency-associated transcripts were maintained (Fig. 1g). Immunostaining revealed that the number of Gata6-positive cells increased, but Oct4 expression appeared to be comparable in Dax1 KD and Luc KD cells (Fig. 1h).

**Figure 1: Dax1 knockdown predisposes ESCs to differentiation but with no loss of self-renewal capacity.**

To rule out shRNA off-target effects, we transfected an expression vector containing Dax1 cDNA (Dax1 OE) into Dax1 KD-5 ESCs. Because cDNA does not contain the 3′ UTR of Dax1, the Dax1 KD-5 construct does not affect this exogenous transcript (Supplementary Fig. 1a,d). Re-expression of Dax1 could completely rescue the upregulation of ExEn markers in Dax1 KD cells (Supplementary Fig. 1e), indicating that the observed phenotypes are specifically due to loss of Dax1 function.

Furthermore, stable Dax1 KD were also generated in an Oct4:GFP reporter iPSC line. We found that Oct4:GFP was expressed in Dax1 KD iPSCs (Supplementary Fig. 1f), whereas Gata6-positive cells increased and were mainly Nanog^low cells (Supplementary Fig. 1g). A colony-forming assay and qRT–PCR analysis for pluripotency and differentiation markers also produced consistent results with that of Dax1 KD ESCs (data not shown). Collectively, these results suggest that a large number of, if not all, Dax1 KD ESCs/iPSCs can maintain undifferentiated states, despite an increased differentiation propensity and reduced self-renewal efficiency.

Dax1 KD ESCs retain multilineage differentiation potential

To assess whether Dax1 KD affects the multilineage differentiation potential of ESCs, we measured marker gene expression in day 9 embryoid bodies (EB) derived from Dax1 KD ESCs. As shown in Fig. 2a, pluripotency genes were downregulated in Dax1 KD cells on EB differentiation similar to Luc KD cells. No consistent significant variation was detected for the transcripts of neuroectoderm, mesoderm and TE, but ExEn markers were upregulated more when compared with control cells (Fig. 2a). Next, we used lineage-specific differentiation models to clarify the effect of Dax1 KD. In the presence of low-dose retinoic acid (RA), which promotes ExEn differentiation²², ~85% of Dax1 KD cells were Gata6 positive, compared with ~60% of Luc KD cells (Fig. 2b). Under conditions for neuroectoderm²³, TE²⁴ or mesoderm²⁵ differentiation, however, expression of lineage-specific markers did not significantly differ from those in control cells (Fig. 2c,d). Notably, Dax1 KD ESCs also had the capacity to generate teratomas consisting of all three germ-derived tissues, suggesting that these cells still maintain pluripotency in vivo (Fig. 2e). These data indicate that Dax1 KD ESCs retain a multilineage differentiation potential, but have an enhanced propensity for differentiating into ExEn lineages.

**Figure 2: Dax1-knockdown ESCs retain multilineage differentiation potential.**

Dax1 OE confers LIF-independent self-renewal on ESCs

To investigate the effect of Dax1 gain of function on ESC self-renewal and pluripotency, full-length cDNA for Dax1 was cloned into the pPyCAGIP-based vector and stable Dax1 OE ESC lines were established. Under +LIF conditions, Dax1 OE cells formed more disorganized semi-differentiated-like colonies (Fig. 3a, left). qRT–PCR and immunostaining analyses showed that expression of some differentiation markers (Flk1, Goosecoid, Cdx2 and Hand1) were upregulated, whereas that of the pluripotency markers were normal (Fig. 3b, upper; Supplementary Fig. 2a). After two passages without LIF, the control cells (empty vector-transfected) underwent complete differentiation. In contrast, Dax1 OE cells could form undifferentiated AP-positive colonies with a typical ESC morphology (Fig. 3a, right; Fig. 3c,d). Both mRNAs and proteins examined for lineage markers’ expression showed that, in the absence of LIF, expression of Oct4 and Nanog continued, and all differentiation markers were significantly repressed in Dax1 OE cells (Fig. 3b, lower; Fig. 3e). Cell proliferation experiments showed that despite reduced growth and increased apoptosis under +LIF conditions (Fig. 3f; Supplementary Fig. 2b), Dax1 OE ESCs could be serially passaged without LIF (Fig. 3g).

**Figure 3: Dax1 overexpression confers LIF-independent self-renewal on ESCs.**

Overexpression of Dax1 at high levels creates the possibility of neomorphic effects, which may impair self-renewal of ESCs by sequestering other pluripotency factors, as reported previously^26,27. We therefore used low-dose puromycin selection to generate an ESC line expressing Dax1 at nearly endogenous levels (Dax1-NE; Supplementary Fig. 2c). In contrast to the pro-differentiation phenotype induced by Dax1 OE, these cells exhibited normal ESC morphology and marker gene expression under +LIF conditions, with only a slight reduction in the AP-positive colony-forming and proliferation ability (Supplementary Fig. 2d–h). However, in the absence of LIF, Dax1-NE ESCs recapitulate the phenotype of Dax1 OE cells, including: (1) undifferentiated morphology (Supplementary Fig. 2d); (2) continuous expression of pluripotency genes; (3) decreased expression of differentiation markers (Supplementary Fig. 2e); and (4) capacity to form self-renewing colonies (Supplementary Fig. 2f,g) and to expand (Supplementary Fig. 2h). Taken together, these results indicate that Dax1 can prevent differentiation and confer LIF-independent self-renewal in ESCs, but it may not be a self-renewal-promoting factor.

Dax1 directly inhibits Gata6 transcription

The above observations suggested that Dax1 may play a role in inhibiting ExEn differentiation, in which Gata6 transcriptional activation is the key¹¹. We thus performed chromatin immunoprecipitation (ChIP) to assess whether Dax1 binds to the Gata6 locus in vivo. Significantly, an enhanced enrichment of Dax1 on Gata6 proximal promoter was observed (Fig. 4a). To rule out other pluripotency factors that may mediate Dax1 binding to the Gata6 promoter, we co-transfected 3Flag-Dax1 expression vector and the Gata6 proximal promoter fragment into 293FT cells. ChIP-qPCR analysis validated that Dax1 specifically bound to this DNA segment (Supplementary Fig. 3a).

**Figure 4: Inhibition of ExEn differentiation by Dax1 is mediated by Gata6.**

To determine whether the binding was associated with the regulation of Gata6 transcription, we performed a luciferase assay. Data showed that Gata6 promoter activity was repressed by Dax1 OE and increased by Dax1 KD (Fig. 4b). Likewise, Dax1 OE effectively repressed Gata6 promoter activity in RA-treated differentiated cells (Supplementary Fig. 3b), in which Gata6 expression was activated, whereas Oct4 and Nanog were undetectable²². These results suggest that Dax1 can repress Gata6 transcription in the absence of other pluripotent factors. To map the Dax1-binding region, we generated serial deletion Gata6 promoter/enhancer reporter constructs. The luciferase assay indicated that the Dax1-binding motif was located between −710 and −570 bp of the Gata6 promoter (Supplementary Fig. 3c).

To verify whether Dax1-mediated Gata6 repression contributes to the ExEn differentiation defect of Dax1 OE ESCs, we compared phenotypes of Dax1 OE, Gata6 OE and Dax1 OE/Gata6 OE cells (Fig. 4c). Under +LIF conditions, Gata6 OE and Dax1 OE/Gata6 OE cells exhibited a completely differentiated morphology (Fig. 4d). No AP-positive colonies appeared in these cell cultures (Supplementary Figs 3d and 4e). mRNA and protein analyses showed that pluripotency markers were lost and ExEn lineage markers were strongly upregulated in both Gata6 OE and Dax1 OE/Gata6 OE cells (Fig. 4f,g; Supplementary Fig. 3e). These data indicate that as a downstream target of Dax1, Gata6 can compensate for ExEn differentiation defects caused by Dax1 OE.

Dax1 and Nanog function in parallel to maintain pluripotency

Features of Dax1 strongly suggest a functional similarity to Nanog^8,9,15. Analysis using published microarray data sets^28,29 showed that, in contrast to significant downregulation after Oct4 or Sox2 KD, pluripotency genes only slightly changed with respect to expression after Dax1 or Nanog KD (Supplementary Fig. 4a), as validated by qRT–PCR (Supplementary Fig. 4b). After 72 h of Dax1 and Nanog depletion, 242 and 761 genes were differentially expressed, respectively, and 133 genes were common (Supplementary Fig. 4c). In contrast, 298 and 490 genes had ≥1.5-fold expression changes after induction of Dax1 or Nanog (Supplementary Fig. 4d). The statistically significant P values were corrected using the Benjamini and Hochberg false discovery rate test (FDR<0.05)³⁰. Interestingly, only nine differentially expressed genes were found in both Dax1 OE and Nanog OE ESCs, suggesting that they may function independently.

To better understand the functional relationship between Dax1 and Nanog, we compared the phenotypic differences on Nanog KD, Dax1 KD and Dax1 plus Nanog KD (Dax1 KD/Nanog KD) in ESCs under LIF conditions (Fig. 5a). Nanog KD cells could be continuously propagated and form undifferentiated AP-positive colonies that express Oct4 and Dax1, despite an increase in differentiated-like cells and upregulation of ExEn markers (Fig. 5a–e). These phenotypes resembled those of Dax1 KD cells (Fig. 5a–e) and were consistent with the previously described phenotypes of Nanog^−/− cells¹⁵. In contrast to individual KD cells, Dax1 KD/Nanog KD cells were fully differentiated and could not generate AP-positive colonies. Oct4 expression was markedly downregulated, and ExEn differentiation markers were significantly further upregulated (Fig. 5a–e), indicating that a simultaneous depletion of Dax1 and Nanog induces terminal differentiation of ESCs even in the presence of LIF.

**Figure 5: Dax1 and Nanog function in parallel and independently to regulate pluripotency of ESCs.**

In addition to Nanog, Klf4 and Esrrb have also been shown to be dispensable for ESC self-renewal. Artificial expression of Klf4 or Esrrb is sufficient to maintain pluripotency in the absence of LIF^{31,32,33,34,35}. Therefore, functional analyses of the single KD, as well as double KD of each gene with Dax1 and Nanog were performed in parallel. Two shRNA sequences, which have been previously validated^35,36, were used to silence Klf4 and Esrrb, respectively (Supplementary Fig. 5a). In accordance with previous studies^35,37,38, no obvious phenotypic changes were observed in Klf4 KD cells, whereas Esrrb KD cells displayed an increased differentiation propensity, with the upregulation of TE and neuroectoderm markers (Supplementary Fig. 5b–d). By comparison, however, Dax1/Klf4, Dax1/Esrrb, Nanog/Klf4 and Nanog/Esrrb double KD all showed significantly weaker additive effects than Dax1/Nanog KD (Supplementary Fig. 5b–d).

Next, to test whether Nanog and Dax1 are functionally redundant, we measured the expression of ExEn markers in Dax1 KD/Nanog OE and Nanog KD/Dax1 OE cells. Immunoblotting analysis showed that both Dax1 and Nanog were comparably overexpressed after transfection (Supplementary Fig. 6a,b). Under +LIF conditions, Dax1 could not completely rescue increased expression of ExEn markers induced by Nanog KD. Also, Nanog could not completely rescue the effect of Dax1 KD (Fig. 6a). Under RA-induced differentiation conditions, individual Dax1 OE or Nanog OE effectively inhibited the expression of Gata6 and formed undifferentiated AP-positive colonies. In contrast, both Dax1 KD/Nanog OE and Nanog KD/Dax1 OE cells could not completely suppress Gata6 upregulation, although they partially retained the capacity to form AP-positive colonies (Fig. 6b; Supplementary Fig. 6c). These results indicate that functions of Dax1 and Nanog are partially complementary but cannot replace each other, even though they are overexpressed.

**Figure 6: Functions of Dax1 and Nanog are partially complementary but they cannot replace each other.**

Collectively, these data suggest that Nanog is not a downstream effector of Dax1, and vice versa. These two factors most likely function in a parallel and cooperative manner to maintain pluripotency.

Dax1 is indispensable for self-renewal of Nanog^low ESCs

ESCs have been reported to fluctuate between a Nanog^high and a Nanog^low state¹⁵. In contrast, Dax1 was uniformly expressed in ESCs (Supplementary Fig. 7a). Nanog KD could induce Gata6 expression in Dax1⁺ cells, whereas Dax1 KD induced Gata6 derepression mainly in Nanog⁻ cells and in only a minority of Nanog⁺ cells (Supplementary Fig. 7b–d). In addition, fluorescence-activated cell sorting (FACS)-sorted Nanog^low ESCs had reduced expression of Klf4 and Esrrb but relatively normal expression of Oct4 and Dax1 (Supplementary Fig. 7e). These results are consistent with the previous findings that Klf4 and Esrrb are direct downstream targets of Nanog^33,34, and suggest that Dax1, but not Klf4 or Esrrb, is required for preventing Nanog^low ESCs from differentiating. To confirm this, we established stable Dax1 KD in Nanog:GFP reporter ESCs (Supplementary Fig. 7f).

In agreement with previous reports¹⁵, GFP^high (green fluorescent protein) and GFP^low populations sorted from control (Luc KD) cells were interconvertible, although GFP^low cells showed obviously reduced ability of self-renewal and proliferation (Fig. 7). Comparatively, Dax1 KD-Nanog:GFP^high populations exhibited a higher self-renewal efficiency than Luc KD-Nanog:GFP^low cells. However, upregulated ExEn marker expression as well as reduced colony-forming and proliferation abilities were observed in contrast to control Nanog:GFP^high cells (Fig. 7b–g), indicating a relatively increased differentiation propensity in Dax1 KD-Nanog^high cells. In contrast, Dax1 KD-Nanog:GFP^low populations had more dramatically upregulated ExEn transcripts and were hardly expanded (Fig. 7b–g), indicating that Dax1 KD-Nanog^low cells cannot survive and/or self-renew. Accordingly, Dax1 KD-GFP^high cells regenerated GFP^low cells, but GFP^low cells could not give rise to GFP^high cells (Fig. 7a,f). These data suggest that Dax1 is not only essential but also sufficient for stabilizing ESC pluripotency during the dynamic transition between Nanog^high and Nanog^low states.

**Figure 7: Dax1 is indispensable for self-renewal of Nanog^low ESC.**

Dax1 is required for full somatic cell reprogramming

Given the importance of Dax1 in pluripotency maintenance, we then asked whether it is necessary for efficient somatic cell reprogramming. Dax1 expression was absent in mouse embryonic fibroblasts (MEFs) but upregulated during iPSC generation alongside Nanog, Sox2 and Rex1 (Fig. 8a; Supplementary Fig. 8a). It has been reported that Dax1 is not in the original reprogramming factor cocktail Oct4, Sox2, Klf4 and c-Myc (OSKM)³. Moreover, addition of Dax1 to this quartet has not been shown to increase efficiencies³⁹. However, whether Dax1 is, like Nanog⁴⁰, required for attaining pluripotency at the final stage of the reprogramming process is unclear. Thus, we introduced Dax1 RNA interference lentivirus into Oct4-GFP MEFs⁴¹ together with OSKM reprogramming factors (Fig. 8b).

**Figure 8: Dax1 and Nanog are both required for full reprogramming to induce pluripotency.**

In our experiment, cell colonies started to emerge at day 9 post infection. After AP staining at day 18, no differences were found between Luc KD and Dax1 KD, as well as Nanog KD MEFs (Fig. 8c). As described previously⁴², rarer cells were GFP positive at this stage, indicating incomplete induced reprogramming (Fig. 8d). After replating onto gelatin-coated dishes and inducing for an additional 6 days, an estimated 25.4% of control cells were GFP positive. But in Dax1 KD cells, this ratio was <3.2%, which was approximate to that of Nanog KD cells (Fig. 8d). A significant decrease in the number of Nanog/Oct4-GFP-positive colonies and a marked reduced endogenous Sox2 and Rex1 expression were observed in both Dax1 KD and Nanog KD MEF-derived cells (Fig. 8e,f). Notably, these cells were SSEA-1 positive and proliferation was not adversely affected (Fig. 8d; Supplementary Fig. 8b). A similar reprogramming block was also observed when we used a clonal line of Oct4-GFP MEF-derived pre-iPSCs. This cell line expressed SSEA-1 and was able to spontaneously give rise to fully reprogrammed cells after passaging⁴³. As Supplementary Fig. 8c–e showed, SSEA-1 expression was unchanged in both Dax1 KD and Nanog KD pre-iPSCs, but the GFP-positive cells appeared at a significantly lower frequency after prolonged culture, in comparison with control pre-iPSCs. These data suggest that Dax1 is not required for the initiation phase but may play a role in acquiring the authentic pluripotency at the final stage of somatic cell reprogramming.

Relationship of Dax1 with other ESC regulators

Activation of STAT3, a key downstream transcription factor of the LIF/gp130 pathway, is sufficient and necessary for self-renewal in ESCs⁴⁴. Dax1 OE can maintain ESC self-renewal without LIF, but STAT3 activation was affected by neither Dax1 OE nor Dax1 KD in the presence or absence of LIF (Fig. 9a). Suppression of the extracellular signal-regulated kinase (ERK) pathway, which is also activated by LIF signalling, promotes self-renewal of ESCs⁴⁵. Total ERK and ERK phosphorylation were shown to be indistinguishable in WT, Dax1 OE or Dax1 KD cells (Fig. 9a). Therefore, Dax1 OE ESC self-renewal in LIF-independent cultures is an unlikely consequence of directly activating STAT3, or suppression of the ERK pathway.

Oct4 is a master regulator for ESC pluripotency. Dax1 KD or OE had no significant effect on Oct4 expression, whereas Oct4 KD reduced Dax1 and Oct4 OE increased Dax1 mRNA levels as early as 12 h post transfection (Fig. 9b). ChIP-qPCR analysis showed that Oct4 bound to the promoter of Dax1, whereas the enrichment of Dax1 on the Oct4 gene locus (spanning from ~5 kb upstream to 2 kb downstream) was not observed (Fig. 9c,d). These results and those of previous reports⁴⁶ support that Dax1 is a direct downstream target of Oct4.

We then examined the functional relationship between Dax1 and Oct4. Although forced expression of Dax1 conferred LIF-independent self-renewal of ESCs, Dax1 OE could not prevent differentiation induced by Oct4 KD, as shown by colony-forming assays (Fig. 9e,f). These data indicate that Oct4 persistence is required for Dax1-mediated self-renewal. Nevertheless, Dax1 OE could partially rescue Oct4 KD-induced upregulation of ExEn and TE markers’ expression (Fig. 9g), suggesting that the function of Oct4 in the maintenance of pluripotency is at least partly mediated by Dax1.

It has been reported that Dax1 binds to Oct4 and inhibits its transcriptional activity in ESCs, which in turn induces TE differentiation²⁶. Consistently, our earlier findings showed that Dax1 OE led to an increased expression of TE markers (Fig. 3b). However, we also found that Dax1 KD induced the derepression of Cdx2 and Eomes without altering Oct4 expression (Fig. 1f,g) and, moreover, Dax1 OE rescued Oct4 KD-induced upregulation of these transcription factors to a large extent (Fig. 9g). These data therefore suggest that Dax1 can inhibit TE differentiation independently or as a downstream effector of Oct4.

Discussion

Dax1, a member of the orphan nuclear receptor superfamily, has been suggested to play important roles in reproductive development, sex determination, steroidogenesis and tumorigenesis^47,48,49. Attempts to generate Dax1-knockout mice have failed⁵⁰, suggesting an early role in embryogenesis. Loss of function of Dax1 has been reported to induce ESC differentiation, but the phenotypes arising from stable suppression of Dax1 have not been observed in these studies (Supplementary Table 1). Specifically, there was no evidence to show that Dax1 KD induced a significant downregulation of pluripotent markers. In the present study, we observed that stable Dax1 KD ESC lines can be established and maintained in culture by serial passages. Dax1 KD ESCs are prone to differentiation, but retain pluripotency despite reduced self-renewal efficiency. That Dax1 KD decreases the proliferation of ESCs suggests that Dax1-null ESCs cannot survive, which may be why several laboratories have tried but failed to create Dax1-knockout ESC lines or mice.

Dax1 OE also inhibits the proliferation of ESCs and upregulates some differentiation markers. Nevertheless, Dax1 OE ESCs can be continuously propagated without LIF and maintain self-renewal. These seemingly contradictory phenotypes suggest that Dax1 may not be a self-renewal-promoting factor. In earlier studies, Dax1 OE was reported to induce ESC differentiation because Dax1 binds Oct4 and inhibits its transcriptional activity²⁶. However, we report that Dax1 OE ESCs can be established and retain normal expression of pluripotent markers. This discrepancy may be due to different expression levels of extrinsic Dax1 in ESCs. Sun et al.²⁶ observed the phenotypes of primary transfectants after supertransfection of an episomal expression vector, which directs strong expression of extrinsic Dax1 in ESCs. In this study, we also use the episomal vector system for forced expression of Dax1. However, we obtained stable transfectants by conventional transfection and drug selection. Differentiated cells in response to Dax1 OE were gradually eliminated during the culture.

Cellular phenotypic analysis indicates that Dax1 functions similarly to Nanog in regulating pluripotency. It has been reported that Nanog and its downstream target Esrrb regulate Dax1 transcription^27,51. Our work and that of others¹⁵ suggest that Nanog deficiency in ESCs does not affect expression of Dax1. In contrast, Nanog expression is also persistent in Dax1 KD ESCs. The Dax1 KD phenotype can be completely rescued by Dax1, but only partially rescued by Nanog OE, and vice versa. Moreover, co-knockdown of Dax1 and Nanog shows an additive effect. If Dax1 is simply a downstream effector of Nanog (or the contrary), these results cannot be explained. In fact, high-throughput experiments have also revealed that Dax1 and Nanog are two independent target ‘hubs’ within the ESC pluripotency network¹⁹. Thus, we suggested that Dax1 and Nanog are functionally independent, partially complementary, but ultimately irreplaceable.

Although it is not among the collection of genes for somatic cell reprogramming, Nanog has been proven to be key to the acquisition of both embryonic and induced pluripotency⁴⁰. However, Nanog expression is heterogeneous and dynamic in ESCs/iPSCs. Fluctuating Nanog expression will inevitably lead the gene regulatory network centred around Nanog to be broken and reconstructed repeatedly, and thereby cause fluctuations in cellular function and potential. Thus, maintenance of pluripotency and self-renewal in the absence of Nanog is worthy of understanding. A logical corollary is that different populations of stem cells have networks comprised of different elements but with similar functions to Nanog⁵². Our findings provide experimental evidence not only to support this theoretical model, but also to extend recent reports establishing critical roles for Nanog in true iPSC generation. We therefore proposed a ‘double-insurance’ mechanism that Dax1 and Nanog cooperate to stabilize the ESC and induced pluripotency (Fig. 10a). In ESCs, each factor is necessary but neither Dax1 nor Nanog alone is sufficient to maintain an optimal pluripotent state. Nanog⁺/Dax1⁺ cells possess the most prominent self-renewal efficiency; Nanog⁻/Dax1⁺ ESCs have reduced self-renewal efficiency and an increased ExEn differentiation propensity, whereas Nanog⁻/Dax1⁻ ESCs irreversibly lose pluripotency. As a result, Dax1 is indispensable for keeping Nanog⁻ populations from differentiating. In producing iPSCs, Dax1 and Nanog are both needed to obtain authentic pluripotency at the final stage. Lack of each blocks the transition of reprogramming cells from the intermediate to the maturation phase.

**Figure 10: Dax1 and Nanog offer double insurance for stabilizing ESC and induced pluripotency.**

Both Dax1- and Nanog-deficient ESCs have an increased differentiation propensity for ExEn cells, in which Gata6 is the critical regulator^11,53. Co-knockdown of Dax1 and Nanog induces ExEn commitment, which might be due to full activation of Gata6. The combined effect of Dax1 and Nanog suggests that these two factors may cooperate to control expression of Gata6, and thereby determine the degree of pluripotency in ESCs (Fig. 10a). At this time, no direct evidence for the repression of Gata6 by pluripotent factors has been reported⁵⁴. Our observations show that Dax1 blocks ExEn differentiation by transcriptional repression of Gata6. Early studies suggest that Dax1 may repress gene expression by recruiting co-repressors or by interacting with stem-loop structures^55,56. We identified a putative Dax1-binding site that is located −710 to −570 bp upstream from the transcription start site of the Gata6 gene. Sequence analysis indicates that there is no proper stem-loop structure that can be formed by the DNA. Thus, other mechanisms may contribute to Dax1-mediated transcriptional regulation of Gata6. Nanog has also been reported to bind to the proximal region of the Gata6 promoter^14,57, indicating the tight control of this crucial target gene by Dax1 and Nanog in ESCs.

Oct4 is the core regulator of ESC pluripotency. Oct4 OE can also upregulate the expression of Gata6¹². However, because Oct4 expression is not affected by Dax1 KD and Gata6 is only weakly induced by Oct4 OE¹¹, we suggest that the predisposition of Dax1 KD ESCs to differentiate into ExEn is Oct4 independent. Both Dax1 and Nanog are regulated by Oct4 at the transcriptional level^46,58, and they also form negative- and positive-feedback loops with Oct4, respectively^27,59. This model would balance expression and functional activity of Oct4 (Fig. 10b), and thereby ensure the ability of ESCs to self-renew and appropriately respond to differentiation signals.

The interaction between Oct4 and Cdx2, which form a complex for the reciprocal repression of their target genes in ESCs, has been shown to regulate TE lineage determination¹³. It was reported that a 50% decrease in Oct4 induces TE differentiation¹². However, recent studies indicate that reduced Oct4 expression (up to sevenfold) directs a more robust pluripotent state^60,61. This discrepancy may suggest that Oct4 is not an exclusive factor responsible for inhibiting TE differentiation. Here we observed that both KD and OE of Dax1 lead to derepression of Cdx2 expression, but the mechanisms involved may be different. Given that Dax1 OE induced Cdx2 upregulation is due to Oct4 activity inhibition²⁶, Dax1 KD-induced derepression of Cdx2 and Dax1 OE rescuing the Oct4 KD-induced Cdx2 upregulation should not be caused by functional inhibition of Oct4. Thus, these data suggest that Cdx2 can be regulated in an Oct4-independent manner, and conversely, Dax1 is required, at least partially, for Oct4-mediated Cdx2 repression. We suggest that Dax1 may play an important role in TE differentiation by interacting with Cdx2 and/or Eomes (Fig. 10b). Future studies should elucidate such mechanisms.

In conclusion, our findings reveal functional relationships of Dax1 with Nanog and Oct4, and provide new insights into the molecular mechanisms underlying somatic cell reprogramming and the dynamic equilibrium of pluripotent states. Mouse and human ESCs fluctuate between the primed state, in which they are ready for lineage commitment, and the naive/ground state, in which they have enhanced self-renewal efficiency and even totipotent properties^60,62,63,64. Understanding the mechanism for stabilizing the pluripotent state is required for exploiting the full potential of ESCs and creating high-quality iPSCs. Further experiments will be needed to demonstrate the exact biological role of Dax1 in stem cell state determination and elucidate precisely the interconnection between Dax1 and other pluripotency-regulating factors.

Methods

Plasmid construction

pLL3.7 vector (provided by Luk Van Parijs) was modified by replacing the EGFP gene with the zeocin or hygromycin-resistance gene. All shRNA-targeting sequences (Supplementary Table 5) were designed and BLASTed to ensure specificity. The oligonucleotides encoding target shRNA were cloned as described before⁶⁵. pPyCAGIP expression vector (a gift from Ian Chambers) was modified by replacing the IRES-pac cassette with the 2A sequence hygromycin-resistance gene. The new vector was named pCAG-2AH. The full-length open reading frames of Dax1, Nanog and Gata6 were PCR amplified from mouse ESC cDNA using KOD-Plus- (TOYOBO) and cloned into pGEM-T Easy (Promega). After DNA sequence verification, the open reading frames were subcloned into pPyCAGIP or pCAG-2AH. For construction of Flag-tagged expression vectors, the 3 × FLAG fragments were obtained from p3 × FLAG-CMV plasmid via PCR, and subcloned in-frame into the respective expression vectors. Gata6 promoter (positions −2,097 to +13, −1,007 to +13, −863 to +13, −710 to +13, −570 to +13 and −280 to +13) and enhancer (positions +247 to +1,539) fragments were amplified by PCR from mouse genomic DNA and inserted into pGL3-basic vector (Promega). The primers for construction are listed in Supplementary Table 6. The DNA sequences of these plasmids are available on request.

Cell culture

Mouse ESC lines and iPSCs (Supplementary Table 2), including R1 (American Type Culture Collection), CCE (Stemcell Technologies), E14/T (provided by Ian Chambers), Nanog:GFP (a gift from Shaorong Gao) and iP14D (a gift from Qi Zhou), and their derivatives were cultured on 0.2% gelatin-coated plates in ESC medium (DMEM, 5% ES cell-qualified fetal bovine serum (FBS), 15% KSR, 2 mM GlutaMAX, 1 mM sodium pyruvate, 0.1 mM non-essential amino acids, 0.1 mM β-mercaptoethanol (all from Invitrogen) and 10 ng ml⁻¹ LIF (Milipore)). Cells were routinely propagated by trypsinization and replated every 2–3 days, with a split ratio of 1 in 8. 293FT cells (Invitrogen) were maintained in DMEM supplemented with 10% FBS. All cell cultures were maintained at 37 °C with 5% CO₂.

ESC transfection

The plasmid DNA was transfected using Lipofectamine 2000 (Invitrogen) according to the manufacturer’s instructions. Cells were cultured in the presence of 2 μg ml⁻¹ puromycin (Invitrogen) or 200 μg ml⁻¹ hygromycin B (Invitrogen) for the indicated number of days. For stable transfection, resistant colonies were pooled and expanded for further analysis.

ESC differentiation

To form EBs, ESCs were trypsinized to single-cell suspensions, plated at a density of 5 × 10⁴ cells per ml in petri dishes and cultured in LIF-deficient ESC medium for the indicated number of days. The medium was changed at 2-day intervals.

For the ExEn differentiation, cells in monolayer were treated with 0.1 μM RA^22,66. Four days later, cells were fixed with paraformaldehyde and stained with Gata6, Gata4 or Foxa2 antibody.

Induction of mesodermal cells was performed as described²⁵ with minor modifications. Briefly, 3 × 10⁴ ESCs were seeded in each well of collagen IV-coated six-well cluster dishes (BD Biosciences) and incubated for 4 days in α-MEM with 10% FBS and 50 μM β-mercaptoethanol. Cells were collected with cell dissociation buffer (Invitrogen) and analysed for expression of Flk1 by flow cytometry.

Neuroectoderm differentiation was performed as reported²³. Briefly, 1.5 × 10⁵ ESCs were cultured in six-well plates in ESC medium. After 24 h of culture, the ESC medium was replaced by differentiation medium (advanced DMEM/F12 and neurobasal media (1:1), 1 × N2, 1 × B27, 2 mM GlutaMAX, 1 mM sodium pyruvate, 0.1 mM non-essential amino acids, 0.1 mM β-mercaptoethanol, 25 μg ml⁻¹ insulin and 50 μg ml⁻¹ bovine serum albumin). Six days later, cells were fixed with paraformaldehyde and stained with anti-Nestin antibody.

Trophoblast stem (TS) cell differentiation assays were performed as previously described²⁴, 2 × 10⁵ ESCs were cultured in six-well plates in ESC medium without LIF for 42 h. Wnt3a (50 ng ml⁻¹) was subsequently added to the culture. After 6 h, cells were trypsinized and replated on six-well plates (1 × 10⁴ cells per well) in TS medium. The TS medium consisted of 70% MEF-conditioned medium, 30% RPMI1640 (Invitrogen) supplemented with 10% FBS, 1 mM sodium pyruvate, 0.1 mM non-essential amino acids, 0.1 mM β-mercaptoethanol, 2 μg ml⁻¹ sodium heparin (Sigma) and 25 ng ml⁻¹ recombinant fibroblast growth factor 4 (Sigma). Six days later, cells were fixed with paraformaldehyde and stained with the anti-Cdx2 antibody.

Lentiviral production

Lentiviral vector, pSPAX2 and pMD2G (4:3:1) were co-transfected into 293FT cells by calcium phosphate transfection. Briefly, 293FT cells were grown to 80% confluence in DMEM/10% FBS. Then, 12.5 μg total plasmids were mixed with 50 μl CaCl₂ (2.5 mM) and diluted with 1/10 TE buffer (1 mM Tris–HCl, 0.1 mM EDTA, pH 7.6) to a final volume of 0.5 ml. The mixture was added dropwise to 0.5 ml 2 × HeBS (HeBS contains 0.28 M NaCl, 0.05 M HEPES, 1.5 mM Na₂HPO₄, pH 7.0) and mixed. After 1 min, the solution was mixed again and added dropwise into the media. Then, 12 h later, the medium was changed and virus was collected after a subsequent 48–72 h cultivation. Viral supernatant was centrifuged (10 min at 300 g; 4 °C) to remove cell debris. Viral particles were concentrated by ultracentrifugation at 70,000 g for 2 h.

Lentiviral infection of ESCs

ESCs were trypsinized and infected in suspension by the viral supernatant along with polybrene (4 μg ml⁻¹; Sigma) for 30 min at 37 °C. Cells were then plated at a density of 1 × 10⁴ cells in 24-well plates. After 48 h, cells were trypsinized, replated at 1 × 10⁴ cells per gelatin-coated 10-mm dish and cultured in ESC medium supplemented with 15 μg ml⁻¹ zeocin (Invitrogen) or 200 μg ml⁻¹ hygromycin B (Invitrogen) for 7 days.

Somatic cell reprogramming

iPSCs were induced as previously described^67,68. Briefly, MEFs (passage 2–4) were seeded in gelatin-coated six-well plates at a density of 1 × 10⁵ cells per well (day −2). Cells were infected with TetO-4F2A and M2rtTA lentivirus together with pLL3.7-based lentivirus for shRNAs (day 0). Infections were performed in the presence of 8 μg ml⁻¹ polybrene and 1 μg ml⁻¹ doxycycline. Two days later, culture medium was replaced by ESC medium supplemented with doxycycline (1 μg ml⁻¹) and changed daily. On day 18, cells were trypsinized and replated onto gelatin-coated plates at a density of 5 × 10³ cells per cm². Six days later (day 24), cells were collected for analysis.

Cell proliferation and colony formation assay

For proliferation assay, cells were plated at a density of 200 cells per cm² in gelatin-coated dishes and cultured in the presence or absence of LIF. Cells were counted at the indicated time points. Viable cells were determined by Trypan blue exclusion and manually counted using a haemocytometer under light microscopy.

For colony formation assay, ESCs were plated at clonal density (50 cells per cm²) and cultured in the presence (1 ng ml⁻¹) or absence of LIF. After 6 days, AP was measured with a BCIP/NBT alkaline phosphatase detection kit (Beyotime) according to the manufacturer’s instructions. Colonies were scored in three categories: undifferentiated, mixed (partially differentiated) and differentiated.

Immunofluorescence

Cells were fixed in 4% paraformaldehyde for 20 min at 4 °C and permeabilized with 0.1% Triton X-100 for 15 min, followed by blocking with 10% FBS/phosphate-buffered saline (PBS) for 30 min. Cells were stained overnight with primary antibodies at 4 °C, followed by the appropriate secondary antibodies detecting mouse and rabbit IgG. A list of antibodies and dilution ratios is available in the Supplementary Table 4. Cell nuclei were visualized by staining with DAPI (4',6-diamidino-2-phenylindole). Images were captured with a confocal microscope (SP1, Leica Microsystems) or inverted biological microscope (Olympus, IX71).

Protein extraction and immunoblotting

To obtain whole-cell extracts, cells were washed with PBS and incubated for 20 min in cold lysis buffer containing freshly added protease inhibitors (Beyotime). Protein concentrations were determined using BCA protein assay (Beyotime). Total protein (10 μg) was separated by SDS–PAGE and transferred to polyvinylidene difluoride membranes (Millipore). Membranes were probed with specific primary antibodies, antibody–protein complex detected by horseradish peroxidase-conjugated secondary antibodies and enhanced chemiluminescence (ECL) exposed (Pierce). Representative full-length images of immunoblots are shown in Supplementary Fig. 9.

Flow cytometry analysis

Cells were collected using cell dissociation buffer (Invitrogen). To examine the expression of Flk1, cells were resuspended at ~5 × 10⁵ cells per ml in PBS. Phycoerythrin-conjugated anti-Flk1 antibody (eBioscience) was added, cells were incubated at 4 °C for 30 min and washed in PBS. For intracellular antigens (Oct4, Nanog, Dax1 and Gata6) staining, 5 × 10⁵ cells were washed with PBS and resuspended in 1 ml Foxp3 Fixation/Permeabilization working solution (eBioscience) at 4 °C for 60 min in dark. After washing two times with Permeabilization Buffer (eBioscience), the pellet was resuspended in 100 μl 1 × Permeabilization Buffer, blocked with 2% bovine serum albumin/PBS at room temperature for 15 min followed by incubation with the recommended amount of antibody (Supplementary Table 4) at 4 °C for 60 min. Fluorochrome-conjugated secondary antibodies (Supplementary Table 4) were added for 20 min at room temperature. After washing twice with Permeabilization Buffer, cells were analysed using a FACS Calibur or FACS Aria (Becton Dickinson).

Teratoma formation

Six-week-old male nude mice with BALB/c genetic background were used in the experiments. Mice were housed in specific pathogen-free conditions. All of the animal experiments were approved by the Animal Ethical and Experimental Committee of Third Military Medical University. ESCs were collected, washed twice with PBS and injected subcutaneously into the posterior flanks of nude mice (2 × 10⁶ cells per injection). Three mice were used for each cell line. After 4 weeks, mice were killed. Tumours were fixed with 4% formaldehyde, sectioned and stained with hematoxylin and eosin.

Luciferase assay

Briefly, 0.5 μg of luciferase reporter was co-transfected into ESCs or 293FT cells using Lipofectamine 2000 with 0.01 μg of pRL-SV40 (Promega) as an internal control. Transfectants were lysed at 48 h after transfection and luciferase activities were measured using Dual-luciferase Reporter Assay System (Promega).

Real-time PCR analysis

Total RNA was isolated with Trizol reagent (Invitrogen) according to the manufacturer’s recommendation. First-strand cDNA was synthesized from 1 μg of total RNA in a 10 μl reaction with oligo dT primer using the Transcriptor High Fidelity cDNA Synthesis Kit (Roche). Real-time PCR reaction was performed with the ExTaq SYBR Green Supermix (Takara) using the Eco real-time PCR System (illumina). Each PCR reaction generated a specific amplicon, as demonstrated by melting-temperature profiles of final products (dissociation curve analysis). No PCR products were observed in the absence of template. In gene expression analysis, all data were normalized to Gapdh and shown relative to a control sample (set at 1.0). The qPCR primers are listed in Supplementary Table 3.

Chromatin immunoprecipitation

ChIP was performed using the ChIP Assay Kit (Upstate Biotechnology) according to the manufacturer’s instructions. Briefly, cells were crosslinked with 1% formaldehyde for 10 min at room temperature, and quenched by the 125 mM glycine. Chromatin extracts containing DNA fragments with an average size of 500 bp were immunoprecipitated using Flag antibody (Beyotime). For all ChIP experiments, qPCR analyses were performed using the Eco real-time PCR System (Illumina) and SYBR green master mix, as described above. Enrichment was calculated relative to input. The ChIP-qPCR primers are listed in Supplementary Table 7.

Microarray analysis

Microarray data used in this study were downloaded from GEO database at NCBI ( http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE26520). Heatmaps were generated by Hierarchical Clustering in Cluster 3.0 and visualized using Java Treeview. Differentially expressed genes were identified based on the systematic analysis by global gene expression profiling of ESCs after KD or induction of series transcription factors^28,29. The analysis was performed at NIA Array Analysis database ( http://lgsun.grc.nia.nih.gov/ANOVA/index.html), via pair-wise statistical comparison between microarray data by analysis of variance and FDR carried out using the Benjamini–Hochberg method³⁰. Differentially expressed genes were identified according to the statistical criteria (FDR <0.05 and expression fold change ≥1.5). Overlap of differentially expressed genes was analysed using venn diagram analysis tool developed for ArrayTrack ( http://www.fda.gov/ScienceResearch/BioinformaticsTools/Arraytrack/).

Statistical analysis

Statistical analysis was performed using the Statistical Package for Social Science (SPSS for Windows package release 13.0; SPSS, Chicago, IL). Student’s t-test was used to analyse statistical differences. Data in the figures were expressed as mean±s.d. or mean±s.e.m., and P<0.05 was considered significant. Each experiment was performed at least three times.

Additional information

How to cite this article: Zhang, J. et al. Dax1 and Nanog act in parallel to stabilize mouse embryonic stem cells and induced pluripotency. Nat. Commun. 5:5042 doi: 10.1038/ncomms6042 (2014).

References

Evans, M. J. & Kaufman, M. H. Establishment in culture of pluripotential cells from mouse embryos. Nature 292, 154–156 (1981).
Article ADS CAS PubMed Google Scholar
Murry, C. E. & Keller, G. Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development. Cell 132, 661–680 (2008).
Article CAS PubMed Google Scholar
Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663–676 (2006).
Article CAS PubMed Google Scholar
Ng, H. H. & Surani, M. A. The transcriptional and signalling networks of pluripotency. Nat. Cell Biol. 13, 490–496 (2011).
Article CAS PubMed Google Scholar
Jaenisch, R. & Young, R. Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming. Cell 132, 567–582 (2008).
Article CAS PubMed PubMed Central Google Scholar
Festuccia, N., Osorno, R., Wilson, V. & Chambers, I. The role of pluripotency gene regulatory network components in mediating transitions between pluripotent cell states. Curr. Opin. Genet. Dev. 23, 504–511 (2013).
Article CAS PubMed PubMed Central Google Scholar
Orkin, S. H. et al. The transcriptional network controlling pluripotency in ES cells. Cold Spring Harb. Symp. Quant. Biol. 73, 195–202 (2008).
Article CAS PubMed Google Scholar
Mitsui, K. et al. The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 113, 631–642 (2003).
Article CAS PubMed Google Scholar
Chambers, I. et al. Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 113, 643–655 (2003).
Article CAS PubMed Google Scholar
Ralston, A. & Rossant, J. Genetic regulation of stem cell origins in the mouse embryo. Clin. Genet. 68, 106–112 (2005).
Article CAS PubMed Google Scholar
Fujikura, J. et al. Differentiation of embryonic stem cells is induced by GATA factors. Genes Dev. 16, 784–789 (2002).
Article CAS PubMed PubMed Central Google Scholar
Niwa, H., Miyazaki, J. & Smith, A. G. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat. Genet. 24, 372–376 (2000).
Article CAS PubMed Google Scholar
Niwa, H. et al. Interaction between Oct3/4 and Cdx2 determines trophectoderm differentiation. Cell 123, 917–929 (2005).
Article CAS PubMed Google Scholar
Singh, A. M., Hamazaki, T., Hankowski, K. E. & Terada, N. A heterogeneous expression pattern for Nanog in embryonic stem cells. Stem Cells 25, 2534–2542 (2007).
Article CAS PubMed Google Scholar
Chambers, I. et al. Nanog safeguards pluripotency and mediates germline development. Nature 450, 1230–1234 (2007).
Article ADS CAS PubMed Google Scholar
Zanaria, E. et al. An unusual member of the nuclear hormone receptor superfamily responsible for X-linked adrenal hypoplasia congenita. Nature 372, 635–641 (1994).
Article ADS CAS PubMed Google Scholar
Wang, J. et al. A protein interaction network for pluripotency of embryonic stem cells. Nature 444, 364–368 (2006).
Article ADS CAS PubMed Google Scholar
van den Berg, D. L. et al. An Oct4-centered protein interaction network in embryonic stem cells. Cell Stem Cell 6, 369–381 (2010).
Article CAS PubMed PubMed Central Google Scholar
Kim, J., Chu, J., Shen, X., Wang, J. & Orkin, S. H. An extended transcriptional network for pluripotency of embryonic stem cells. Cell 132, 1049–1061 (2008).
Article CAS PubMed Google Scholar
Khalfallah, O., Rouleau, M., Barbry, P., Bardoni, B. & Lalli, E. Dax-1 knockdown in mouse embryonic stem cells induces loss of pluripotency and multilineage differentiation. Stem Cells 27, 1529–1537 (2009).
Article CAS PubMed Google Scholar
Clipsham, R., Niakan, K. & McCabe, E. R. Nr0b1 and its network partners are expressed early in murine embryos prior to steroidogenic axis organogenesis. Gene. Expr. Patterns 4, 3–14 (2004).
Article CAS PubMed Google Scholar
Capo-Chichi, C. D. et al. Perception of differentiation cues by GATA factors in primitive endoderm lineage determination of mouse embryonic stem cells. Dev. Biol. 286, 574–586 (2005).
Article CAS PubMed Google Scholar
Ying, Q. L., Stavridis, M., Griffiths, D., Li, M. & Smith, A. Conversion of embryonic stem cells into neuroectodermal precursors in adherent monoculture. Nat. Biotechnol. 21, 183–186 (2003).
Article CAS PubMed Google Scholar
He, S., Pant, D., Schiffmacher, A., Meece, A. & Keefer, C. L. Lymphoid enhancer factor 1-mediated Wnt signaling promotes the initiation of trophoblast lineage differentiation in mouse embryonic stem cells. Stem Cells 26, 842–849 (2008).
Article CAS PubMed Google Scholar
Nishikawa, S. I., Nishikawa, S., Hirashima, M., Matsuyoshi, N. & Kodama, H. Progressive lineage analysis by cell sorting and culture identifies FLK1+VE-cadherin+ cells at a diverging point of endothelial and hemopoietic lineages. Development 125, 1747–1757 (1998).
CAS PubMed Google Scholar
Sun, C. et al. Dax1 binds to Oct3/4 and inhibits its transcriptional activity in embryonic stem cells. Mol. Cell. Biol. 29, 4574–4583 (2009).
Article CAS PubMed PubMed Central Google Scholar
Uranishi, K., Akagi, T., Sun, C., Koide, H. & Yokota, T. Dax1 associates with Esrrb and regulates its function in embryonic stem cells. Mol. Cell. Biol. 33, 2056–2066 (2013).
Article CAS PubMed PubMed Central Google Scholar
Nishiyama, A. et al. Systematic repression of transcription factors reveals limited patterns of gene expression changes in ES cells. Sci. Rep. 3, 1390 (2013).
Article PubMed PubMed Central Google Scholar
Nishiyama, A. et al. Uncovering early response of gene regulatory networks in ESCs by systematic induction of transcription factors. Cell Stem Cell 5, 420–433 (2009).
Article CAS PubMed PubMed Central Google Scholar
Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate-a practical and powerful approach to multiple testing. J. R. Stat. Soc. B 57, 289–300 (1995).
MathSciNet MATH Google Scholar
Niwa, H., Ogawa, K., Shimosato, D. & Adachi, K. A parallel circuit of LIF signalling pathways maintains pluripotency of mouse ES cells. Nature 460, 118–122 (2009).
Article ADS CAS PubMed Google Scholar
van den Berg, D. L. et al. Estrogen-related receptor beta interacts with Oct4 to positively regulate Nanog gene expression. Mol. Cell. Biol. 28, 5986–5995 (2008).
Article CAS PubMed PubMed Central Google Scholar
Festuccia, N. et al. Esrrb is a direct Nanog target gene that can substitute for Nanog function in pluripotent cells. Cell Stem Cell 11, 477–490 (2012).
Article CAS PubMed PubMed Central Google Scholar
Martello, G. et al. Esrrb is a pivotal target of the Gsk3/Tcf3 axis regulating embryonic stem cell self-renewal. Cell Stem Cell 11, 491–504 (2012).
Article CAS PubMed PubMed Central Google Scholar
Jiang, J. et al. A core Klf circuitry regulates self-renewal of embryonic stem cells. Nat. Cell Biol. 10, 353–360 (2008).
Article PubMed Google Scholar
Loh, Y. H. et al. The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nat. Genet. 38, 431–440 (2006).
Article CAS PubMed Google Scholar
Mitsunaga, K. et al. Loss of PGC-specific expression of the orphan nuclear receptor ERR-beta results in reduction of germ cell number in mouse embryos. Mech. Dev. 121, 237–246 (2004).
Article CAS PubMed Google Scholar
Ivanova, N. et al. Dissecting self-renewal in stem cells with RNA interference. Nature 442, 533–538 (2006).
Article ADS CAS PubMed Google Scholar
Zhao, Y. et al. Two supporting factors greatly improve the efficiency of human iPSC generation. Cell Stem Cell 3, 475–479 (2008).
Article CAS PubMed Google Scholar
Silva, J. et al. Nanog is the gateway to the pluripotent ground state. Cell 138, 722–737 (2009).
Article CAS PubMed PubMed Central Google Scholar
Kang, L. et al. Viable mice produced from three-factor induced pluripotent stem (iPS) cells through tetraploid complementation. Cell Res. 21, 546–549 (2011).
Article CAS PubMed Google Scholar
Brambrink, T. et al. Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells. Cell Stem Cell 2, 151–159 (2008).
Article CAS PubMed PubMed Central Google Scholar
Meissner, A., Wernig, M. & Jaenisch, R. Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells. Nat. Biotechnol. 25, 1177–1181 (2007).
Article CAS PubMed Google Scholar
Niwa, H., Burdon, T., Chambers, I. & Smith, A. Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3. Genes Dev. 12, 2048–2060 (1998).
Article CAS PubMed PubMed Central Google Scholar
Burdon, T., Stracey, C., Chambers, I., Nichols, J. & Smith, A. Suppression of SHP-2 and ERK signalling promotes self-renewal of mouse embryonic stem cells. Dev. Biol. 210, 30–43 (1999).
Article CAS PubMed Google Scholar
Sun, C. et al. Stem cell-specific expression of Dax1 is conferred by STAT3 and Oct3/4 in embryonic stem cells. Biochem. Biophys. Res. Commun. 372, 91–96 (2008).
Article CAS PubMed Google Scholar
Lalli, E. & Alonso, J. Targeting DAX-1 in embryonic stem cells and cancer. Expert Opin. Ther. Targets 14, 169–177 (2010).
Article CAS PubMed Google Scholar
Muscatelli, F. et al. Mutations in the DAX-1 gene give rise to both X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism. Nature 372, 672–676 (1994).
Article ADS CAS PubMed Google Scholar
Swain, A., Narvaez, V., Burgoyne, P., Camerino, G. & Lovell-Badge, R. Dax1 antagonizes Sry action in mammalian sex determination. Nature 391, 761–767 (1998).
Article ADS CAS PubMed Google Scholar
Yu, R. N., Ito, M., Saunders, T. L., Camper, S. A. & Jameson, J. L. Role of Ahch in gonadal development and gametogenesis. Nat. Genet. 20, 353–357 (1998).
Article CAS PubMed Google Scholar
Kelly, V. R. & Hammer, G. D. LRH-1 and Nanog regulate Dax1 transcription in mouse embryonic stem cells. Mol. Cell. Endocrinol. 332, 116–124 (2011).
Article CAS PubMed Google Scholar
Kalmar, T. et al. Regulated fluctuations in nanog expression mediate cell fate decisions in embryonic stem cells. PLoS Biol. 7, e1000149 (2009).
Article PubMed PubMed Central Google Scholar
Koutsourakis, M., Langeveld, A., Patient, R., Beddington, R. & Grosveld, F. The transcription factor GATA6 is essential for early extraembryonic development. Development 126, 723–732 (1999).
CAS PubMed Google Scholar
Niwa, H. How is pluripotency determined and maintained? Development 134, 635–646 (2007).
Article CAS PubMed Google Scholar
Iyer, A. K. & McCabe, E. R. Molecular mechanisms of DAX1 action. Mol. Genet. Metab. 83, 60–73 (2004).
Article CAS PubMed Google Scholar
Zazopoulos, E., Lalli, E., Stocco, D. M. & Sassone-Corsi, P. DNA binding and transcriptional repression by DAX-1 blocks steroidogenesis. Nature 390, 311–315 (1997).
Article ADS CAS PubMed Google Scholar
Fidalgo, M. et al. Zfp281 functions as a transcriptional repressor for pluripotency of mouse embryonic stem cells. Stem Cells 29, 1705–1716 (2011).
Article CAS PubMed PubMed Central Google Scholar
Rodda, D. J. et al. Transcriptional regulation of nanog by OCT4 and SOX2. J. Biol. Chem. 280, 24731–24737 (2005).
Article CAS PubMed Google Scholar
Boyer, L. A. et al. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 122, 947–956 (2005).
Article CAS PubMed PubMed Central Google Scholar
Karwacki-Neisius, V. et al. Reduced Oct4 expression directs a robust pluripotent state with distinct signaling activity and increased enhancer occupancy by Oct4 and Nanog. Cell Stem Cell 12, 531–545 (2013).
Article CAS PubMed PubMed Central Google Scholar
Radzisheuskaya, A. et al. A defined Oct4 level governs cell state transitions of pluripotency entry and differentiation into all embryonic lineages. Nat. Cell Biol. 15, 579–590 (2013).
Article CAS PubMed PubMed Central Google Scholar
Ying, Q. L. et al. The ground state of embryonic stem cell self-renewal. Nature 453, 519–523 (2008).
Article ADS CAS PubMed PubMed Central Google Scholar
Morgani, S. M. et al. Totipotent embryonic stem cells arise in ground-state culture conditions. Cell Rep. 3, 1945–1957 (2013).
Article CAS PubMed PubMed Central Google Scholar
Nichols, J. & Smith, A. Pluripotency in the embryo and in culture. Cold Spring Harb. Perspect. Biol. 4, a008128 (2012).
Article PubMed PubMed Central Google Scholar
Rubinson, D. A. et al. A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat. Genet. 33, 401–406 (2003).
Article CAS PubMed Google Scholar
Cho, L. T. et al. Conversion from mouse embryonic to extra-embryonic endoderm stem cells reveals distinct differentiation capacities of pluripotent stem cell states. Development 139, 2866–2877 (2012).
Article CAS PubMed PubMed Central Google Scholar
Gao, Y. et al. Replacement of Oct4 by Tet1 during iPSC induction reveals an important role of DNA methylation and hydroxymethylation in reprogramming. Cell Stem Cell 12, 453–469 (2013).
Article CAS PubMed Google Scholar
Carey, B. W. et al. Reprogramming of murine and human somatic cells using a single polycistronic vector. Proc. Natl Acad. Sci. USA 106, 157–162 (2009).
Article ADS CAS PubMed Google Scholar

Download references

Acknowledgements

We are grateful to Dr Ian Chambers for the pPyCAGIP plasmid. Thanks to Drs Qi Zhou and Shaorong Gao for the iPS cell lines and Oct4-GFP MEFs. We also thank Drs Bohai Wen and Wenyue Xu for their support with our research. This work was supported in part by grants from the National Natural Science Foundation of China (30700418, 31171261, 30800983, 81270893, 81228023, BWS11J041) and Science & Technology Support Program of Sichuan Province (2008SZ0108).

Author information

Junlei Zhang, Gaoke Liu, Yan Ruan and Jiali Wang: These authors contributed equally to this work

Authors and Affiliations

Department of Microbiology, Third Military Medical University, Chongqing, 400038, China
Junlei Zhang, Gaoke Liu & Fu-Quan Hu
Department of Pathogenic Biology, Third Military Medical University, Chongqing, 400038, China
Yan Ruan & Rui Jian
Department of Physiology, Third Military Medical University, Chongqing, 400038, China
Jiali Wang
Laboratory of Oncology, Affiliated Hospital of Academy of Military Medical Sciences, Beijing, 400038, China
Ke Zhao & Bing Liu
Biomedical Analysis Center, Third Military Medical University, Chongqing, 100071, China
Ying Wan
Department of Immunology, Third Military Medical University, Chongqing, 400038, China
Ying Wan
Department of Endocrinology, Xinqiao Hospital, Third Military Medical University, Chongqing, 400037, China
Hongting Zheng
Research Center of Laboratory Medicine, Chengdu Military General Hospital, Sichuan, 610083, China
Tao Peng
Department of Cardiothoracic Surgery, Southwest Hospital, Third Military Medical University, Chongqing, 400038, China
Wei Wu & Ping He

Authors

Junlei Zhang
View author publications
You can also search for this author in PubMed Google Scholar
Gaoke Liu
View author publications
You can also search for this author in PubMed Google Scholar
Yan Ruan
View author publications
You can also search for this author in PubMed Google Scholar
Jiali Wang
View author publications
You can also search for this author in PubMed Google Scholar
Ke Zhao
View author publications
You can also search for this author in PubMed Google Scholar
Ying Wan
View author publications
You can also search for this author in PubMed Google Scholar
Bing Liu
View author publications
You can also search for this author in PubMed Google Scholar
Hongting Zheng
View author publications
You can also search for this author in PubMed Google Scholar
Tao Peng
View author publications
You can also search for this author in PubMed Google Scholar
Wei Wu
View author publications
You can also search for this author in PubMed Google Scholar
Ping He
View author publications
You can also search for this author in PubMed Google Scholar
Fu-Quan Hu
View author publications
You can also search for this author in PubMed Google Scholar
Rui Jian
View author publications
You can also search for this author in PubMed Google Scholar

Contributions

All authors contributed to the design of the experiments. J.Z., G.L. and Y.R. performed experiments. All authors contributed to the analysis and interpretation of data. J.W. and R.J. wrote the manuscript.

Corresponding authors

Correspondence to Fu-Quan Hu or Rui Jian.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Figures, Tables and References

Supplementary Figures 1-9, Supplementary Tables 1-7 and Supplementary References (PDF 2109 kb)

Rights and permissions

This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

Reprints and permissions

About this article

Cite this article

Zhang, J., Liu, G., Ruan, Y. et al. Dax1 and Nanog act in parallel to stabilize mouse embryonic stem cells and induced pluripotency. Nat Commun 5, 5042 (2014). https://doi.org/10.1038/ncomms6042

Download citation

Received: 18 February 2014
Accepted: 20 August 2014
Published: 06 October 2014
DOI: https://doi.org/10.1038/ncomms6042

This article is cited by

A multi-omics integrative analysis based on CRISPR screens re-defines the pluripotency regulatory network in ESCs
- Yan Ruan
- Jiaqi Wang
- Rui Jian
Communications Biology (2023)
Leydig Cell–Specific DAX1-Deleted Mice Has Higher Testosterone Level in the Testis During Pubertal Development
- Sudeep Kumar
- Hyo Jeong Kim
- Keesook Lee
Reproductive Sciences (2022)
Novel frameshift mutation of the NR0B1(DAX1) in two tall adult brothers
- Rita Bertalan
- Zsuzsa Bencsik
- Attila Patócs
Molecular Biology Reports (2019)
Ground rules of the pluripotency gene regulatory network
- Mo Li
- Juan Carlos Izpisua Belmonte
Nature Reviews Genetics (2017)
The transcriptomes of novel marmoset monkey embryonic stem cell lines reflect distinct genomic features
- Katharina Debowski
- Charis Drummer
- Rüdiger Behr
Scientific Reports (2016)

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.